Biotricity Inc. (BTCY): Price and Financial Metrics


Biotricity Inc. (BTCY): $0.81

-0.07 (-7.70%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

BTCY Stock Summary

  • BIOTRICITY INC's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 5.46% of US listed stocks.
  • BTCY's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 3.87% of US stocks.
  • With a year-over-year growth in debt of 453.38%, BIOTRICITY INC's debt growth rate surpasses 96.11% of about US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to BIOTRICITY INC are BSQR, TIVC, OFIX, SSD, and MYO.
  • Visit BTCY's SEC page to see the company's official filings. To visit the company's web site, go to www.biotricity.com.

BTCY Valuation Summary

  • In comparison to the median Healthcare stock, BTCY's price/sales ratio is 153.66% higher, now standing at 5.2.
  • Over the past 60 months, BTCY's price/earnings ratio has gone up 10.7.

Below are key valuation metrics over time for BTCY.

Stock Date P/S P/B P/E EV/EBIT
BTCY 2023-01-20 5.2 -3.7 -1.7 -2.3
BTCY 2023-01-19 5.0 -3.5 -1.6 -2.2
BTCY 2023-01-18 5.1 -3.6 -1.6 -2.3
BTCY 2023-01-17 5.4 -3.8 -1.7 -2.4
BTCY 2023-01-13 5.0 -3.5 -1.6 -2.2
BTCY 2023-01-12 4.8 -3.3 -1.5 -2.2

BTCY's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • BTCY has a Quality Grade of D, ranking ahead of 17.94% of graded US stocks.
  • BTCY's asset turnover comes in at 1.211 -- ranking 13th of 186 Medical Equipment stocks.
  • BDX, MYO, and DXCM are the stocks whose asset turnover ratios are most correlated with BTCY.

The table below shows BTCY's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 1.211 0.571 9.723
2021-03-31 1.039 0.447 20.815
2020-12-31 0.739 0.532 -366.209
2020-09-30 0.636 0.475 38.103
2020-06-30 0.663 0.446 61.574
2020-03-31 0.588 0.488 18.057

BTCY Price Target

For more insight on analysts targets of BTCY, see our BTCY price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $6.50 Average Broker Recommendation 1.5 (Moderate Buy)

BTCY Stock Price Chart Interactive Chart >

Price chart for BTCY

BTCY Price/Volume Stats

Current price $0.81 52-week high $3.40
Prev. close $0.88 52-week low $0.40
Day low $0.80 Volume 254,900
Day high $0.89 Avg. volume 217,306
50-day MA $0.80 Dividend yield N/A
200-day MA $1.10 Market Cap 42.29M

Biotricity Inc. (BTCY) Company Bio


Biotricity, Inc. is a medical technology company, which is focused on biometric data monitoring solutions. It also involves in delivering, remote monitoring solutions to the medical, healthcare, and consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. The firm’s FDA-approved Bioflux MCT technology, is comprised of a monitoring device and software components, which is made available to the market, in order to assess, establish and develop sales processes, and market dynamics. The company was founded by Waqaas Al-Siddiq and Peter McGoldrick on August 29, 2012 and is headquartered in Redwood City, CA.


BTCY Latest News Stream


Event/Time News Detail
Loading, please wait...

BTCY Latest Social Stream


Loading social stream, please wait...

View Full BTCY Social Stream

Latest BTCY News From Around the Web

Below are the latest news stories about BIOTRICITY INC that investors may wish to consider to help them evaluate BTCY as an investment opportunity.

Biotricity to Participate in the Healthcare IT Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Wednesday, January 25th at 8:15 A.M. ET

Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, announced today that Company CEO Waqaas Alsiddiq has been invited to present at the Healthcare IT Virtual Conference, presented by Maxim Group LLC and hosted by M-Vest, on Wednesday, January 25th, 2023 at 8:15 a.m.

Yahoo | January 23, 2023

Biotricity, Inc.: Biotricity Signs with Top 5 Group Purchasing Organization; Potential for Higher Sales Volume in 2023

REDWOOD CITY, CA / ACCESSWIRE / January 17, 2023 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, announced it has s…

Finanz Nachrichten | January 17, 2023

Biotricity Signs with Top 5 Group Purchasing Organization; Potential for Higher Sales Volume in 2023

Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, announced it has signed an agreement with a leading group ‎purchasing organization ("GPO") for national distribution of its cardiac monitoring solutions, Bioflux® and BiotresTM.

Yahoo | January 17, 2023

Biotricity Files FDA 510(k) For Expanded Use Of Its Biotres Cardiac Monitoring Device

Biotricity Inc (NASDAQ: BTCY ) has announced 510(k) submission to the FDA for a new form factor of its Biotres Cardiac Monitoring Device , a three-lead device for ECG and arrhythmia monitoring that is intended for lower-risk patients. Dr. Waqaas Al-Siddiq, Biotricity Founder and … Full story available on Benzinga.com

Benzinga | December 12, 2022

Biotricity, Inc.: Biotricity Files FDA 510(k) for a new Form Factor of its Biotres Cardiac Monitoring Device to Expand its Revenue Growth

Designed to support revenue growth by expanding biotres form factors for the early detection of cardiac arrhythmias in the $5 billion-dollar holter monitor marketREDWOOD CITY, CA / ACCESSWIRE / Dec…

Finanz Nachrichten | December 12, 2022

Read More 'BTCY' Stories Here

BTCY Price Returns

1-mo 55.77%
3-mo -37.21%
6-mo -25.00%
1-year -70.97%
3-year -26.36%
5-year -82.58%
YTD 80.80%
2022 -88.74%
2021 439.08%
2020 17.17%
2019 31.27%
2018 -93.68%

Continue Researching BTCY

Want to see what other sources are saying about Biotricity Inc's financials and stock price? Try the links below:

Biotricity Inc (BTCY) Stock Price | Nasdaq
Biotricity Inc (BTCY) Stock Quote, History and News - Yahoo Finance
Biotricity Inc (BTCY) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7512 seconds.